Fifteen new research projects aimed at bringing innovative medicines to market faster have been selected to receive 246 million Euros from the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The projects will foster understanding of health issues such as diabetes, pain, severe asthma and psychiatric disorders while increasing medicine safety.
Today help is often available for those suffering from high blood pressure in the pulmonary circulation (pulmonary arterial hypertension/PAH). New drugs — so-called endothelin receptor antagonists — make it possible to alleviate the symptoms, improving patients' physical strength and quality of life.
As processes become more complex, the need for increased laboratory safety is paramount. Protecting operators from hazardous substances, aerosol release or spillages is a critical consideration during processes, whether they are mixing substances or dispensing drugs. Of equal importance is the need to protect the substance, or product, from contamination from the operator. Mark Nicholls presents…
Among 2,552 European R&D projects (clinical phases I-III) conducted by small and mid-size biotechnology firms (under 600 employees), 64 are focused on diabetes, according to a large, detailed study carried out by Novumed Life Science Consulting.
The last time medical science enriched clinical practice with new advanced technologies ideas about aetiology and the treatment principles of a great number of diseases changed. Now the dilemma of modification of diagnoses and treatments, including laboratory diagnostics, is a very hot issue in Russia.
An interdisciplinary team of researchers at Brigham and Women's Hospital (BWH) and the Harvard-MIT Division of Health Sciences and Technology has demonstrated a better way to deliver cancer drugs directly to tumors by using specially engineered nanoparticles that can inhibit a signaling pathway and deliver a higher concentration of medication to the specific area.
In a symposium organised by Bayer Schering Pharma at the 2009 European Congress of Radiology (ECR), the audience heard a series of four presentations on the potential advantages of high-signal-intensity contrast agents for MRI, focusing on gadobutrol (Gadovist). During the discussion, several claims made by the speakers were challenged and debated by ECR delegates.
Thanks to cell therapy, researchers have found new ways to understand and potentially treat heart diseases and degenerative conditions such as Parkinson's and cancer. The role of imaging is becoming more and more important, especially in understanding the action of transplanted cells in situ.
When prescribing drugs electronically, US clinicians often over-ride automatic drug warning alerts in computer-based systems, according to a new study led by researchers at the Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Centre (BIDMC), Boston, published in the Archives of Internal Medicine (9/2/09).
UK - Following a six-month study of 3,000 hospital patients in 12 wards in Merseyside, researchers at Liverpool University found that one in seven had suffered adverse drug reactions.
The Netherlands - People in developing countries run health risks from pharmaceutical companies testing drugs on them for the Western market.
The availability of a new opioid-based treatment option, has led pain specialists to believe they may at last be able to solve the age-old problem of how to provide effective chronic pain relief without causing opioid-induced constipation (OIC).
17-21 March Stockholm Sweden
The next two countries to preside over the EU Presidency - the Czech Republic (first half year of 2009) and Sweden (second half) recently presented the priorities of their presidencies for healthcare at the European Health Forum Gastein (EHFG).
The European market for autoimmune disease diagnostics has demonstrated sustained growth due to advances in detection technology and automation, according to a new analysis from Frost & Sullivan (F&S)
The 14th Eppendorf Young Investigator Award 2008, worth ?15,000, was presented at MEDICA in November.
Czech hospitals are seeking powerful inspiration regarding antibiotics (ATB) consumption from France, where a recent public campaign helped to decrease ATB consumption by 30%.
The U.S. Food and Drug Administration (FDA) approved Abbott's TRILIPIX™ (fenofibric acid) delayed-release capsules for use along with diet to help lower triglycerides and LDL cholesterol, and to raise HDL cholesterol in patients with lipid problems.
The current global financial crisis is like to hit Bio-tech and pharmaceutical companies due to a lack of funding for research and the discovery and production of many new drugs, according to Professor David Wield, Director of the Economic and Social Research Council's (ESRC) Edinburgh-based Innogen Centre, and chair of the recent international ESRC conference Genomics and Society: Reinventing…
Volumat MC Agilia is the advanced volumetric infusion pump in the Agilia Range, the new family of intuitive infusion devices developed by Fresenius Kabi, based in Brézins, France.
Is there a case of drug abuse ore not? In case of an emergency physicians need a quick answer to decide about the further treatment. The Dräger DrugTest 5000 could deliver the information of up to six different drug classes within minutes.
BEO MedConsulting BERLIN GmbH, founded in 2000 and headquartered in Berlin since 2005, advises manufacturers on all issues concerning testing and approval of medical devices.
There's little evidence that newer, more expensive drugs work any better than older, cheaper medications. Diabetes, which came 7th in the list of the USA's top mortality causes in 2006, has hit a new high.
A panel of experts, convened by the American Diabetes Association and the European Association for the Study of Diabetes, has issued updated treatment recommendations for type 2 diabetes, in a consensus statement published online in two journals: Diabetes Care and Diabetologia*.
NHS managers are refuting a report that ranks the UK 13th for healthcare out of 31 European countries. The Euro Health Consumer Index 2008 puts the Netherlands in first place, with the UK trailing behind countries including Estonia, France and Germany.